Medical Ikkou Group Co.,Ltd.

During the current interim consolidated accounting period, the Group consisted of the Company, 12 consolidated subsidiaries and 1 other affiliated company, and operated healthcare-related businesses centered on pharmaceuticals. Its 4 principal segments are the dispensing pharmacy business, healthcare business, pharmaceutical wholesale business and real estate business. Segment results are as follows. The disclosure is based on information available as of 31 August 2026. At the end of the interim period, the Group had ¥7,121,358 thousand in cash and cash equivalents, total assets of ¥37,521,984 thousand and an equity ratio of 42.7%. Results through the end of the interim period were net sales of ¥28,255,589 thousand, operating income of ¥821,005 thousand, ordinary income of ¥1,135,761 thousand, interim net income attributable to owners of the parent of ¥850,224 thousand and interim comprehensive income of ¥584,226 thousand. The Group has acquired a pharmaceutical wholesale business in Saga Prefecture and plans to expand its business base by leveraging M&A and other means.